SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Stealth BioTherapeutics Offers Update On Phase 3 Trial Of Elamipretide: Primary Endpoint Not Met

Benzinga · -